Issue: Visual aids for the disabled
Author: AmblyoPlay
Published: 2024/10/15
Post type: Product launch, update
Content: Summary – Introduction – Main article – Related topics
Synopsis: AmblyoPlay launches active peripheral stimulation (APS) aimed at advancing the treatment of peripheral vision deficiencies and improving the effectiveness of at-home vision therapy. APS technology, available within existing AmblyoPlay vision therapy, is designed to improve peripheral vision by actively engaging and stimulating peripheral areas of the retina. People with amblyopia and other binocular vision problems often struggle with depth perception, hand-eye coordination, and reading difficulties and may experience frustration or low self-esteem due to challenges in everyday tasks such as driving, playing sports, and learning.
Why it is important: The introduction of active peripheral stimulation (APS) technology by AmblyoPlay represents a significant advancement in the field of vision therapy, particularly for the treatment of peripheral vision deficiencies. This innovation is notable for several reasons. Firstly, it addresses a widespread problem, since amblyopia affects up to 5% of the world’s population. Second, APS technology actively activates and stimulates peripheral areas of the retina, potentially improving spatial awareness and overall visual function. The integration of APS into AmblyoPlay’s existing gamified vision therapy platform improves the effectiveness of at-home treatments while maintaining user engagement. This approach not only targets visual impairments such as amblyopia, strabismus, and convergence insufficiency, but also addresses associated challenges such as depth perception and hand-eye coordination. By making vision therapy more accessible, engaging and effective, AmblyoPlay’s APS technology could significantly impact the quality of life for people with visual impairments, potentially improving outcomes in daily activities, education and overall well-being. Disabled world.
Introduction
AmblyoPlay, a leading innovator in vision therapy solutions, proudly announces the launch of its revolutionary technology: Active Peripheral Stimulation (APS). APS, which aims to advance the treatment of peripheral vision deficiencies, is an important step toward improving the effectiveness of home vision therapy.
Main article
APS technology, available within existing AmblyoPlay vision therapy, is designed to improve peripheral vision by actively engaging and stimulating peripheral areas of the retina. This unique approach improves the brain’s ability to integrate peripheral inputs, resulting in greater spatial awareness.
While amblyopia (often called “lazy eye”) may seem like a very specific problem, up to 5% of the population suffers from this vision disorder worldwide. However, it remains a major global problem, and public health initiatives for early detection, treatment and management are essential.
Continued…
People with amblyopia and other binocular vision problems often struggle with depth perception, hand-eye coordination, and reading difficulties and may experience frustration or low self-esteem due to challenges in everyday tasks such as driving, playing sports, and learning.
AmblyoPlay raises the bar in the treatment of amblyopia, strabismus, convergence insufficiency and other visual disabilities by incorporating APS technology into vision therapy. Technology has been seamlessly incorporated into therapeutic exercises, ensuring a smooth and engaging experience for users of all ages.
“With APS we are pushing the boundaries of what vision therapy can achieve,” said Matic Vogrič, CEO of AmblyoPlay.
AmblyoPlay Vision Therapy
AmblyoPlay was born from conversations with doctors and parents, all facing a common challenge: how to keep young patients motivated during vision therapy homework. Existing solutions were repetitive and unattractive, leading to frustration. Therefore, AmblyoPlay transformed vision therapy into a gamified experience, turning a routine task into something fun.
Continued…
This playful approach not only keeps patients engaged, but also improves adherence to therapy, helping families and clinicians work together to achieve better vision outcomes.
AmblyoPlay is a vision therapy solution designed to treat vision problems such as amblyopia (lazy eye), strabismus (crossed eyes), convergence insufficiency, double vision, and other binocular vision disorders. Complements in-office vision therapy and increases adherence to at-home vision therapy through gamification.
Offering personalized, evidence-based therapy, AmblyoPlay provides effective solutions for both children and adults, bringing engaging therapy to the comfort of users’ homes.
So far, it has helped more than 25,000 users around the world. Find out more about AmblyoPlay at amblyoplay.com
Related information
Attribution/Source(s):
This quality-reviewed publication was selected for publication by the editors of Disabled World due to its important relevance to the disability community. Originally written by AmblyoPlayand published on 10/15/2024, content may have been edited for style, clarity, or brevity. For more details or clarifications, AmblyoPlay He can be contacted at amblyoplay.com. NOTE: Disabled World does not provide any warranty or endorsement related to this item.
Page information, citations and disclaimer
Disabled World is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004, our website covers a wide range of topics, including disability rights, healthcare, education, employment and independent living, with the goal of supporting the disability community and their families.
Cite this page (APA): AmblyoPlay. (2024, October 15). Revolutionary vision therapy: AmblyoPlay presents the peripheral vision enhancer. Disabled world. Retrieved October 15, 2024 from www.disabled-world.com/assistivedevices/visual/amblyoplay.php
Permanent link: Revolutionary vision therapy: AmblyoPlay presents a peripheral vision enhancer: AmblyoPlay launches active peripheral stimulation (APS) aimed at advancing the treatment of peripheral vision deficiencies and improving the effectiveness of at-home vision therapy.
Disabled World provides general information only. The materials presented are never intended to be a substitute for qualified medical care. Any third party offers or advertisements do not constitute an endorsement.
